Vascular Access News

WASHINGTON — Placement of an arteriovenous fistula in patients with chronic kidney disease not on dialysis can help stabilize GFR, according to a study presented here during ASN Kidney Week.

WASHINGTON — In patients receiving maintenance hemodialysis, acquired thrombotic factors contributed to recurrent arteriovenous fistula clotting, according to data presented at ASN Kidney Week.

WASHINGTON — Acute kidney injury in association with major complications was linked with decreased survival in patients who have undergone coronary artery bypass grafting, according to data presented at ASN Kidney Week.

Researchers found one-fifth of surgeons diverged from recommended best practice guidelines by using an arteriovenous graft — rather than an AV fistula — for initial permanent hemodialysis access, with specific surgeon factors influencing these practice patterns.

Healionics Corporation has raised $4.5 million to help fund a trial on its new vascular access device.

A drug-coated balloon yielded superior patency to percutaneous transluminal angioplasty in patients with de novo or restenotic arteriovenous fistula lesions, according to findings presented at the Cardiovascular and Interventional Radiological Society of Europe Annual Meeting.

A sensor-enhanced needle guide, called the JEM device, that may reduce pain and save costs for patients on dialysis was among the 15 winners of the KidneyX Redesign Dialysis phase 1 competition.

A wearable telehealth device designed to detect thrombosis and clots in vascular access for patients on hemodialysis was awarded $75,000 in funding from the KidneyX Redesign Dialysis Phase 1 competition.

BOSTON — Revisions to guidelines for vascular access placement in the patient with ESKD – the first in 10 years – place a greater emphasis on matching patients’ care plans and modality options with the access choice.

BOSTON — Neutrolin, an investigational new drug containing taurolidine, was shown to reduce catheter-related bloodstream infections among patients with ESRD who were on hemodialysis via a central venous catheter, according to data presented at the National Kidney Foundation Spring Clinical Meetings.